...
search icon
acst-img

Acasti Pharma Inc, Common Stock

ACST

NAQ

$

+$

(%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$34.17M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.52
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.98 L
$3.6 H
$

About Acasti Pharma Inc, Common Stock

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameACSTSectorS&P500

Financials

Mar '20Mar '21Mar '22Mar '23Mar '245YR TREND
Total Revenue-196.00K13.00K--[{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":6.63,"profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Cost of Revenue2.32M76.00K15.59M52.16M11.00K[{"date":"2020-03-31","value":4.45,"profit":true},{"date":"2021-03-31","value":0.15,"profit":true},{"date":"2022-03-31","value":29.89,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":0.02,"profit":true}]
Gross Profit(2.32M)120.00K(15.59M)(52.16M)(11.00K)[{"date":"2020-03-31","value":-1933.33,"profit":false},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":-12990.83,"profit":false},{"date":"2023-03-31","value":-43462.5,"profit":false},{"date":"2024-03-31","value":-9.17,"profit":false}]
Gross Margin(Infinity%)61.22%(119915.38%)(Infinity%)(Infinity%)[{"date":"2020-03-31","value":null,"profit":false},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":-195861.79,"profit":false},{"date":"2023-03-31","value":null,"profit":false},{"date":"2024-03-31","value":null,"profit":false}]
Operating Expenses24.44M10.84M15.34M18.25M11.30M[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":44.34,"profit":true},{"date":"2022-03-31","value":62.77,"profit":true},{"date":"2023-03-31","value":74.67,"profit":true},{"date":"2024-03-31","value":46.24,"profit":true}]
Operating Income(24.44M)(10.72M)(15.59M)15.72M(11.31M)[{"date":"2020-03-31","value":-155.43,"profit":false},{"date":"2021-03-31","value":-68.15,"profit":false},{"date":"2022-03-31","value":-99.15,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-71.95,"profit":false}]
Total Non-Operating Income/Expense(1.03M)(11.42M)4.93M(45.39M)(3.71M)[{"date":"2020-03-31","value":-20.91,"profit":false},{"date":"2021-03-31","value":-231.44,"profit":false},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-919.75,"profit":false},{"date":"2024-03-31","value":-75.09,"profit":false}]
Pre-Tax Income(25.51M)(19.68M)(10.47M)(51.97M)(14.63M)[{"date":"2020-03-31","value":-2551300000,"profit":false},{"date":"2021-03-31","value":-1967800000,"profit":false},{"date":"2022-03-31","value":-1046700000,"profit":false},{"date":"2023-03-31","value":-5197100000,"profit":false},{"date":"2024-03-31","value":-1463000000,"profit":false}]
Income Taxes247.00K(127.00K)(648.00K)(9.54M)(1.78M)[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-51.42,"profit":false},{"date":"2022-03-31","value":-262.35,"profit":false},{"date":"2023-03-31","value":-3863.16,"profit":false},{"date":"2024-03-31","value":-719.43,"profit":false}]
Income After Taxes(25.76M)(19.55M)(9.82M)(42.43M)(12.85M)[{"date":"2020-03-31","value":-2576000000,"profit":false},{"date":"2021-03-31","value":-1955100000,"profit":false},{"date":"2022-03-31","value":-981900000,"profit":false},{"date":"2023-03-31","value":-4242900000,"profit":false},{"date":"2024-03-31","value":-1285300000,"profit":false}]
Income From Continuous Operations(25.51M)(19.68M)(9.82M)(42.43M)(12.85M)[{"date":"2020-03-31","value":-2551300000,"profit":false},{"date":"2021-03-31","value":-1967800000,"profit":false},{"date":"2022-03-31","value":-981900000,"profit":false},{"date":"2023-03-31","value":-4242900000,"profit":false},{"date":"2024-03-31","value":-1285300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income(25.76M)(19.68M)(9.82M)(42.43M)(12.85M)[{"date":"2020-03-31","value":-2576000000,"profit":false},{"date":"2021-03-31","value":-1967800000,"profit":false},{"date":"2022-03-31","value":-981900000,"profit":false},{"date":"2023-03-31","value":-4242900000,"profit":false},{"date":"2024-03-31","value":-1285300000,"profit":false}]
EPS (Diluted)(2.12)(0.92)(0.31)(4.20)(1.45)[{"date":"2020-03-31","value":-211.58,"profit":false},{"date":"2021-03-31","value":-92,"profit":false},{"date":"2022-03-31","value":-31,"profit":false},{"date":"2023-03-31","value":-420,"profit":false},{"date":"2024-03-31","value":-145,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ACST
Current Ratio 6.01

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ACST
ROA (LTM) -11.62%
ROE (LTM) -18.56%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ACST
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ACST
Trailing PE NM
Forward PE NM
P/S (TTM) 208.39
P/B 0.59
Price/FCF NM
EV/R 5.50
EV/Ebitda NM

FAQs

What is Acasti Pharma Inc share price today?

Acasti Pharma Inc (ACST) share price today is $

Can Indians buy Acasti Pharma Inc shares?

Yes, Indians can buy shares of Acasti Pharma Inc (ACST) on Vested. To buy Acasti Pharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ACST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Acasti Pharma Inc be purchased?

Yes, you can purchase fractional shares of Acasti Pharma Inc (ACST) via the Vested app. You can start investing in Acasti Pharma Inc (ACST) with a minimum investment of $1.

How to invest in Acasti Pharma Inc shares from India?

You can invest in shares of Acasti Pharma Inc (ACST) via Vested in three simple steps:

  • Click on Sign Up or Invest in ACST stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Acasti Pharma Inc shares
What is Acasti Pharma Inc 52-week high and low stock price?

The 52-week high price of Acasti Pharma Inc (ACST) is $3.6. The 52-week low price of Acasti Pharma Inc (ACST) is $1.98.

What is Acasti Pharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Acasti Pharma Inc (ACST) is

What is Acasti Pharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Acasti Pharma Inc (ACST) is 0.59

What is Acasti Pharma Inc dividend yield?

The dividend yield of Acasti Pharma Inc (ACST) is 0.00%

What is the Market Cap of Acasti Pharma Inc?

The market capitalization of Acasti Pharma Inc (ACST) is $34.17M

What is Acasti Pharma Inc’s stock symbol?

The stock symbol (or ticker) of Acasti Pharma Inc is ACST

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top